Aphria

(NASDAQ: APHA)
Healthcare  |  Drug Manufacturers—Specialty & Generic
7.73 0.72 10.27%
Stock Price | Nov. 27, 2020, 1 p.m.
6 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 7.01
52 Week Low: 1.95
52 Week High: 7.78
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewery. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including B!NGO, Solei, RIFF, and Broken Coast.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - AM Edition 11/27/20

24 Comments
Yesterday

Premium Cannabis Stocks Review - Pre-Market Edition 11/27/20

7 Comments
3 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/25/20

49 Comments
4 days ago

Premium Weekly Review 11/20/20

2 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/19/20

5 Comments
1 week ago

Premium Weekly Review 11/06/20

3 weeks ago

Premium Cannabis Stocks Review - Pre-Market BOOM Edition 11/06/20

9 Comments
3 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/03/20 (re-send)

4 Comments
3 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 11/03/20

10 Comments
3 weeks ago

Premium Weekly Review 10/16/20

1 month ago